Phase III study of NUC-1031 +cisplatin vs gemcitabine + cisplatinfor first-line treatment of patients with advanced biliary tract cancer(NuTide:121)

Category Primary study
JournalJournal of Clinical Oncology
Year 2021
This article has no abstract
Epistemonikos ID: d270dab249f41ab2225e39497d18103570856ea0
First added on: Feb 12, 2025